<?xml version="1.0" encoding="UTF-8"?>
<p>Clinically, longer duration of fever, severe arthralgia and neurological manifestations were significantly associated with CHIKV. Twenty-one percent of CHIKV positive patients presented with CNS manifestations. This may have prompted the use of acyclovir in management of patients with CHIKV infection at time of admission, in lieu of possible herpes encephalitis. Similar findings of CNS involvement at time of presentation have been reported from India where altered mental status was seen in 56.67% of CHIKV patients requiring admission to intensive care units [
 <xref rid="pntd.0008086.ref015" ref-type="bibr">15</xref>]. Literature from most of the CHIKV endemic region (i.e. Indian Ocean, South Asia, the Pacific islands, Southern Europe, the Caribbean, and South America) have reported neurological manifestation of CHIKV [
 <xref rid="pntd.0008086.ref016" ref-type="bibr">16</xref>].
</p>
